Objective To study the pharmacokinetics of a novel recombinant human granulocyte colonystimulating factor (rhG-CSFa) in rats and to determine the proteolytic ra
<正>HEMANGIOBLASTOMA(HB),a kind of benign tumor with uncertain histogenesis,is characterized by the presence of stromal cells(SCs)and a rich vascular component.